M. Rajeev Shah

Affiliations

  • Large Shareholder, Director at Tyra Biosciences Inc. (TYRA), 2024-11-13
  • Large Shareholder, Director at Septerna Inc. (SEPN), 2024-10-30
  • Large Shareholder, Director at Janux Therapeutics Inc. (JANX), 2024-10-22
  • Large Shareholder at Fulcrum Therapeutics Inc. (FULC), 2024-09-23
  • Large Shareholder, Director at Bicara Therapeutics Inc. (BCAX), 2024-09-18
  • Large Shareholder, Director at Wave Life Sciences Ltd. (WVE), 2024-08-14
  • Large Shareholder at An2 Therapeutics Inc. (ANTX), 2024-08-13
  • Large Shareholder, Director at Artiva Biotherapeutics Inc. (ARTV), 2024-07-24
  • Director at Cidara Therapeutics Inc. (CDTX), 2024-07-22
  • Large Shareholder, Director at Eliem Therapeutics Inc. (ELYM), 2024-07-02
  • Large Shareholder, Director at Acrivon Therapeutics Inc. (ACRV), 2024-06-24
  • Large Shareholder, Director at Ars Pharmaceuticals Inc. (SPRY), 2024-06-24
  • Large Shareholder, Director at Pepgen Inc. (PEPG), 2024-06-21
  • Large Shareholder, Director at Aerovate Therapeutics Inc. (AVTE), 2024-06-20
  • Large Shareholder, Director at Nkarta Inc. (NKTX), 2024-06-14
  • Large Shareholder, Director at Acumen Pharmaceuticals Inc. (ABOS), 2024-06-10
  • Director at Mineralys Therapeutics Inc. (MLYS), 2024-05-28
  • Large Shareholder, Director at Vor Biopharma Inc. (VOR), 2024-05-28
  • Large Shareholder, Director at Werewolf Therapeutics Inc. (HOWL), 2024-05-24
  • Other at Iteos Therapeutics Inc. (ITOS), 2024-05-15
  • Large Shareholder, Director at 89Bio Inc. (ETNB), 2024-04-15
  • Large Shareholder at Boundless Bio Inc. (BOLD), 2024-04-04
  • Large Shareholder, Director at Lenz Therapeutics Inc. (LENZ), 2024-03-26
  • Large Shareholder, Director at Icosavax Inc. (ICVX), 2024-02-21
  • Large Shareholder, Director at Solid Biosciences Inc. (SLDB), 2024-01-12
  • Other at Dice Therapeutics Inc. (DICE), 2023-08-09
  • Director at Black Diamond Therapeutics Inc. (BDTX), 2023-07-07
  • Large Shareholder, Director at Satsuma Pharmaceuticals Inc. (STSA), 2023-06-08
  • Other at Enliven Therapeutics Inc. (ELVN), 2023-02-27
  • Large Shareholder at Forma Therapeutics Holdings Inc. (FMTX), 2022-10-14
  • Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2022-05-26
  • Large Shareholder, Director at Cytek Biosciences Inc. (CTKB), 2022-03-16
  • Large Shareholder at Rxsight Inc. (RXST), 2021-08-13
  • Director at Therapeutics Acquisition Corp. (RACA), 2021-06-24
  • Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2021-03-16
  • Large Shareholder at Phathom Pharmaceuticals Inc. (PHAT), 2021-03-15
  • Large Shareholder, Director at Orchard Therapeutics Plc (ORTX), 2021-02-11
  • Large Shareholder at Iterum Therapeutics Plc (ITRM), 2021-02-08
  • Large Shareholder at Miragen Therapeutics Inc. (MGEN), 2020-12-17
  • Other at Rhythm Pharmaceuticals Inc. (RYTM), 2020-12-04
  • Large Shareholder at Vaxcyte Inc. (PCVX), 2020-10-09
  • Large Shareholder at Cardiff Oncology Inc. (CRDF), 2020-10-02
  • Large Shareholder at Pmv Pharmaceuticals Inc. (PMVP), 2020-09-29
  • Large Shareholder at Dyne Therapeutics Inc. (DYN), 2020-09-23
  • Large Shareholder at Tg Therapeutics Inc. (TGTX), 2020-09-11
  • Large Shareholder at Inhibrx Inc. (INBX), 2020-08-24
  • Large Shareholder at Inozyme Pharma Inc. (INZY), 2020-07-28
  • Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-22
  • Large Shareholder at Akouos Inc. (AKUS), 2020-07-02
  • Large Shareholder at Verastem Inc. (VSTM), 2020-06-29
  • Director at Eidos Therapeutics Inc. (EIDX), 2020-05-29
  • Large Shareholder, Director at Ra Pharmaceuticals Inc. (RARX), 2020-04-03
  • Large Shareholder at Synthorx Inc. (THOR), 2020-01-24
  • Large Shareholder, Director at Kalvista Pharmaceuticals Inc. (KALV), 2017-10-16
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KALA $7.89 6,337,135 Large Shareholder, Director 10,874,613 2020-03-13 Filing
BDTX $19.00 136,539 Director 353,814 2020-02-03 Filing
BDTX $19.00 77,803 Director 311,926 2020-02-03 Filing
BDTX $19.00 785,658 Director 1,924,164 2020-02-03 Filing
STSA $15.00 192,387 Large Shareholder, Director 4,681,858 2019-09-17 Filing